by Commetric | May 24, 2022
Immuno-oncology has continued to be a priority for Big Pharma even during the heights of the Covid pandemic. Commetric’s infographic looks at the media debate around this rapidly developing field, taking into account key topics, companies, spokespeople,...
by Commetric | May 13, 2022
As pharma experiences continued momentum for immuno-oncology treatments, with the current drug development pipeline consisting of thousands of potential therapies and therapy combinations, the media conversation around immuno-oncology is becoming livelier and...
by Commetric | Feb 11, 2022
With the 2022 Olympic Games in Beijing and the World Cup in Qatar, the concept of sportswashing is gaining steam in the media, as critics allege that oppressive governments use sports as a PR tool to legitimise their regimes and distract the public from...
by Commetric | Feb 4, 2022
During the pandemic, global health diseases have been discussed in two main ways: as being put on the sidelines because of the immediate threat of Covid, or as being finally treatable thanks to the advances in vaccine science turbocharged by the crisis. Our media...
by Commetric | Jan 11, 2022
As COVID-19 has unequally affected many racial and ethnic minority groups, the crisis served as a call to action within the public health community, spurring pharma to pursue actionable efforts toward reversing health inequity. Our media analysis found that the top...